Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MMR Genetics is a specialized diagnostic laboratory focused on the identification and analysis of Lynch syndrome, a hereditary condition that significantly increases the risk of colorectal and other cancers. The company provides comprehensive genetic testing for mutations in the DNA mismatch repair (MMR) genes, including MLH1, MSH2, MSH6, and PMS2. By utilizing advanced sequencing and deletion/duplication analysis, MMR Genetics assists clinicians and families in cancer risk assessment and management. The laboratory is CLIA-certified and emphasizes high-quality, expert interpretation of genetic variants associated with hereditary non-polyposis colorectal cancer (HNPCC). Based in Little Rock, Arkansas, the firm serves as a dedicated resource for oncology-related genetic screening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MMR Genetics.